Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Healthy
Both
Healthy
Trial Information
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
RLIP76 is shown to be over expressed in a variety of cancer cells. However, no study has yet
been done on its expression on normal cells. The studies proposed in this project will study
the expression of RLIP76 in blood cells of healthy human subjects in the population of North
Texas region.
Inclusion Criteria:
- Healthy as defined by lack of serious health conditions or diseases
Exclusion Criteria:
- Children, pregnant women, prisoners, persons with any medical condition that
precludes phlebotomy and persons unwilling or unable to provide consent will be
excluded.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Expression of RLIP76 in red blood cells and white blood cells of 100 healthy human subjects.
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Sanjay Awasthi, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of North Texas Health Science Center
Authority:
United States: Institutional Review Board
Study ID:
2008-32
NCT ID:
NCT00762801
Start Date:
September 2008
Completion Date:
September 2011
Related Keywords:
- Healthy
- RLIP76
- RLIP76 plays a role in every stage of cancer, right from evasion of apoptosis and signaling to an uncontrolled growth
Name | Location |
|---|---|
| University of North Texas Health Science Center | Fort Worth, Texas 76109 |
